. 2018 Jun 25;11(2):202–209. doi: 10.3400/avd.oa.17-00132

Table 2 Characteristics of 15 patients who had undergone the graft inclusion technique (GIT).

Patient No.	Age	F/M	Access type	Time after AVF (month)	DM	Indication	Procedure	FV pre (ml/min)	FV post (ml/min)	FV f/u (ml/min)	Ope (min)	Graft length (mm)	f/u (years)	Outcome
					HT
					HL
11	80	F	RC AVF	25	HT	HF/VH	GIT	2,000	880	800	120	40	2.0	Central venous PTA
11	80	F	RC AVF	25	HT	HF/VH	GIT	2,000	880	800	120	40	2.0	Death after 2 years
12	77	F	BB AVF	48	DM	HF/VH	GIT	1,800	780	—	93	40	0.1	Central venous PTA
12	77	F	BB AVF	48	HT	HF/VH	GIT	1,800	780	—	93	40	0.1	Lost to f/u
13	37	M	RC AVF	116	HT	HF/VH	GIT	2,570	950	1,020	88	40	3.6	Seroma, prosthesis exchange to PU graft
14	40	M	RC AVF	43	HT	HF/VH	GIT	2,200	850	490	70	45	1.8	Thrombosis, abandonment
15	54	M	RC AVF	263	DM	HF/NYHA II	GIT	2,800	990	660	96	45	5.4	Graft PTA
					HT									NYHA II→I
					HL									Patent
16	60	M	RC AVF	28	HT	HF	GIT	2,310	990	970	55	40	5.7	Lost to f/u
17	61	M	RC AVF	177	HT	HF/HAIDI (2b)	GIT	2,800	1,180	940	104	50	2.6	Infection of a cannulation site, abandonment
18	55	M	BB AVF	59	HT	HF/VH	GIT	1,470	950	610	135	70	5.3	Central venous PTA
														Graft PTA
														Patent
19	83	M	RC AVF	126	DM	HF/VH	GIT	1,420	590	400	58	30	3.0	Central venous PTA
					HT									Graft PTA
					HL									Patent
20	55	M	BB AVF	83	HT	HF	GIT	2,200	860	740	90	35	3.8	Graft PTA
20	55	M	BB AVF	83	HL	HF	GIT	2,200	860	740	90	35	3.8	Patent
21	64	M	RC AVF	243	HT	HF/VH	GIT	3,610	720	920	107	40	3.3	Central venous PTA
						NYHA II								Graft PTA
														NYHA II→I
														Patent
22	78	M	BB AVF	122	HT	HF/VH	GIT	1,580	920	880	101	35	3.5	Central venous PTA
22	78	M	BB AVF	122	HL	HF/VH	GIT	1,580	920	880	101	35	3.5	Patent
23	59	F	RC AVF	43	HT	HF	GIT	1,860	750	—	61	35	0.1	Lost to f/u
24	64	M	RC AVF	27	HT	HF/VH	GIT	2,720	830	880	63	35	0.8	Central venous PTA
24	64	M	RC AVF	27	HT	HF/VH	GIT	2,720	830	880	63	35	0.8	Lost to f/u
25	71	M	BB AVF	67	DM	HF/NYHA II	GIT	2,600	1,110	980	118	35	1.8	NYHA II→I
					HT									Patent
					HL									Patent
Mean	61.9			98.1				2,262	890	791	90.6	41.0	2.97
±SD	±13			±76				±601	±150	±198	±24.7	±9.5	±1.71

RC AVF: radio-cephalic arteriovenous fistula; BB AVF: brachial basilica arteriovenous fistula; VH: venous hypertension; HF: high flow arteriovenous access; FV: flow volume; pre: preoperation; post: postoperation; ope: operation; f/u: follow-up; PU: polyurethane; HAIDI: hemodialysis access-induced distal ischemia; DM: diabetes mellitus; HT: hypertension; HL: hyperlipidemia; PTA: percutaneous transluminal angioplasty